[go: up one dir, main page]

AR071001A1 - Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada - Google Patents

Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada

Info

Publication number
AR071001A1
AR071001A1 ARP090100994A ARP090100994A AR071001A1 AR 071001 A1 AR071001 A1 AR 071001A1 AR P090100994 A ARP090100994 A AR P090100994A AR P090100994 A ARP090100994 A AR P090100994A AR 071001 A1 AR071001 A1 AR 071001A1
Authority
AR
Argentina
Prior art keywords
exhibit improved
phosphate
bufferized
ophthalmic solutions
improved effectiveness
Prior art date
Application number
ARP090100994A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR071001A1 publication Critical patent/AR071001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A61L12/145—Polymeric quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a composiciones oftálmicas que comprenden un pH entre aproximadamente 6 y aproximadamente 8 y aproximadamente 50 a aproximadamente 1000 ppm de peroxido de hidrogeno y por lo menos un tampon fosfato. Las composiciones oftálmicas de la presente exhiben eficacia antifungica mejorada contra hongos, que incluyen candidas albicans y fusarium solani.
ARP090100994A 2008-03-19 2009-03-19 Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada AR071001A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3789408P 2008-03-19 2008-03-19
US12/399,681 US20090239954A1 (en) 2008-03-19 2009-03-06 Phosphate buffered ophthalmic solutions displaying improved efficacy

Publications (1)

Publication Number Publication Date
AR071001A1 true AR071001A1 (es) 2010-05-19

Family

ID=41089519

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090100992A AR070999A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas que muestran una eficacia mejorada
ARP090100994A AR071001A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP090100992A AR070999A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas que muestran una eficacia mejorada

Country Status (12)

Country Link
US (2) US20090239954A1 (es)
EP (2) EP2271313A1 (es)
JP (2) JP2011515393A (es)
KR (2) KR20100126512A (es)
CN (2) CN101977591A (es)
AR (2) AR070999A1 (es)
AU (2) AU2009226112A1 (es)
BR (2) BRPI0909000A2 (es)
CA (2) CA2718864A1 (es)
RU (2) RU2010142462A (es)
TW (2) TW200950822A (es)
WO (2) WO2009117057A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
WO2011001461A1 (ja) 2009-06-29 2011-01-06 株式会社メニコン コンタクトレンズの消毒システム
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
JP2011251932A (ja) * 2010-06-01 2011-12-15 Mandom Corp 点眼剤及び洗眼剤
CN104136017A (zh) * 2012-02-27 2014-11-05 日本乐敦制药株式会社 眼科用组合物
US20160074321A1 (en) * 2013-03-27 2016-03-17 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
US9259437B2 (en) 2013-05-23 2016-02-16 Smm Ventures, Llc Scleral lens solution
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
EP3784354A1 (en) 2018-04-27 2021-03-03 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
CN114318343A (zh) * 2020-09-29 2022-04-12 上海飞凯材料科技股份有限公司 一种蚀刻液及其应用
TW202439971A (zh) * 2022-12-21 2024-10-16 美商壯生和壯生視覺關懷公司 眼科裝置之組成物
TW202434214A (zh) * 2022-12-21 2024-09-01 美商壯生和壯生視覺關懷公司 眼科裝置之組成物(二)
TW202430231A (zh) * 2022-12-21 2024-08-01 美商壯生和壯生視覺關懷公司 眼用裝置之組成物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
US5277901A (en) * 1990-01-05 1994-01-11 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5019380A (en) * 1990-04-27 1991-05-28 Bausch & Lomb Incorporated Novel antimicrobial compositions and process for preparing the same
US5523012A (en) * 1991-07-19 1996-06-04 Ciba-Geigy Corporation Hydrogen peroxide disinfection solutions
DE4132259A1 (de) * 1991-09-27 1993-04-01 Wild Heerbrugg Ag Ueberstrahlungsschutz fuer ein nachtsichtgeraet
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
ES2199956T3 (es) * 1992-12-17 2004-03-01 Advanced Medical Optics, Inc. Solucion desinfectante de lentes de contacto que contiene un agente oxidante y polivinilpirrolidona.
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
JP2839819B2 (ja) * 1993-05-28 1998-12-16 株式会社東芝 不揮発性半導体記憶装置
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
FR2751634B1 (fr) * 1996-07-29 1998-09-11 Essilor Int Solution stabilisee et tamponnee de peroxyde d'hydrogene, son procede de fabrication et son utilisation a la decontamination de lentilles de contact
US5746972A (en) * 1996-11-01 1998-05-05 Allergan Compositions and methods for disinfecting and cleaning contact lenses
WO2000019981A1 (en) * 1998-10-08 2000-04-13 Karagoezian Hampar L Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
WO2000026334A1 (en) * 1998-10-30 2000-05-11 Metrex Research Corporation Simultaneous cleaning and decontaminating compositions and methods
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
TWI236377B (en) * 2000-09-28 2005-07-21 Novartis Ag Stabilized hydrogen peroxide solutions
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
US8466174B2 (en) * 2006-03-17 2013-06-18 Johnson & Johnson Vision Care, Inc. Methods for stabilizing oxidatively unstable compositions
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions

Also Published As

Publication number Publication date
KR20100135813A (ko) 2010-12-27
BRPI0909763A2 (pt) 2015-10-06
EP2271313A1 (en) 2011-01-12
JP2011515394A (ja) 2011-05-19
US20090239775A1 (en) 2009-09-24
BRPI0909000A2 (pt) 2015-08-04
TW201000149A (en) 2010-01-01
AU2009226112A1 (en) 2009-09-24
TW200950822A (en) 2009-12-16
CA2718866A1 (en) 2009-09-24
AU2009226113A1 (en) 2009-09-24
WO2009117057A1 (en) 2009-09-24
US20090239954A1 (en) 2009-09-24
CN101977590A (zh) 2011-02-16
CN101977591A (zh) 2011-02-16
AR070999A1 (es) 2010-05-19
WO2009117056A1 (en) 2009-09-24
JP2011515393A (ja) 2011-05-19
RU2010142462A (ru) 2012-04-27
EP2276462A1 (en) 2011-01-26
KR20100126512A (ko) 2010-12-01
RU2010142488A (ru) 2012-04-27
CA2718864A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
AR071001A1 (es) Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
UY32838A (es) "composición activa herbicida que comprende benzoxazinonas
CL2011001810A1 (es) Cepa de saccharomyces cerevisiae; composicion fitosanitaria que la comprende; y procedimiento de tratamiento o proteccion de plantas contra enfermedades provocadas por agentes patogenos.
MX2009002090A (es) Sustancias sanitarias, desinfectantes, y/o esterilizantes acuosas con bajo contenido de peróxido de hidrógeno.
CR8112A (es) Composiciones antisepticas, metodos y sistemas
EP2293693A4 (en) ANTIMICROBIAL PERSONIC COMPOSITIONS WITH SELECTED CATALASE CYCLES AND METHOD FOR USE IN ASEPTIC PACKAGING
AR059228A1 (es) Supresion del crecimiento microbiano en pulpa y papel
CR20110043A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas
MX2009003378A (es) Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos.
MY149529A (en) Novel agricultural composition
CR20110667A (es) Composiciones activas herbicidas que comprenden benzoxazinonas
DOP2010000225A (es) Arilpirrolinas insecticidas
MA42164A1 (fr) Composes biheteroaryle et leurs utilisations
CO6280437A2 (es) Una composicion de emulsion de aceite en agua que tiene una fase de agua y nua fase de aceite comprendiendo un modificador polimerico y un compuesto activo agricolamente
CR20110406A (es) Mezclas pesticidas
MX2008014369A (es) Soluciones desinfectantes sinergicamente mejoradas.
MX2012006881A (es) Composiciones de povidona-yodo oftalmicas no irritantes.
MX2010007603A (es) Combinacion biocida para utilizacion en aplicaciones agricolas.
UY31051A1 (es) Mezclas fungicidas
CL2009001600A1 (es) Composicion que comprende una fuente de dioxido de cloro, al menos 5 ppm de dioxido de cloro y no mas de 0,25 mg de aniones oxicloro por gramo de composiicon; util para aliviar infecciones de tejido en la cavidad oral.
CR20120521A (es) Combinaciones de principios activos
MX2012006803A (es) Soluciones oftalmicas con perfices de desinfeccion mejorados.
UY32143A (es) Concentrados liquidos de principios activos, emulsionables en agua
TW200833243A (en) Suspension concentrates for improving root uptake of agrochemically active compounds

Legal Events

Date Code Title Description
FB Suspension of granting procedure